Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171162 | 12617116 | 2 | F | 20160803 | 20160803 | 20160811 | EXP | US-APOTEX-2016AP009998 | APOTEX | 56.00 | YR | F | Y | 0.00000 | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171162 | 12617116 | 1 | PS | CIPROFLOXACIN HYDROCHLORIDE. | CIPROFLOXACIN HYDROCHLORIDE | 1 | Unknown | HIGH DOSE | U | 76896 | TABLET | ||||||||
| 126171162 | 12617116 | 2 | SS | CIPROFLOXACIN HYDROCHLORIDE. | CIPROFLOXACIN HYDROCHLORIDE | 1 | U | 76896 | TABLET | ||||||||||
| 126171162 | 12617116 | 3 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 4 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | RESTARTED | 0 | ||||||||||
| 126171162 | 12617116 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | BRIEFLY | 0 | ||||||||||
| 126171162 | 12617116 | 6 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | RESTARTED | 0 | ||||||||||
| 126171162 | 12617116 | 7 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 8 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | UNK | U | 0 | CAPSULE, HARD | ||||||||
| 126171162 | 12617116 | 9 | SS | DAPTOMYCIN. | DAPTOMYCIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 10 | SS | DAPTOMYCIN. | DAPTOMYCIN | 1 | 0 | ||||||||||||
| 126171162 | 12617116 | 11 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 12 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 13 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 14 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 15 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | 1 G, TID | 0 | 1 | G | TID | |||||||
| 126171162 | 12617116 | 16 | SS | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126171162 | 12617116 | 17 | SS | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | 0 | ||||||||||||
| 126171162 | 12617116 | 18 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126171162 | 12617116 | 1 | Staphylococcal infection |
| 126171162 | 12617116 | 2 | Enterobacter infection |
| 126171162 | 12617116 | 3 | Staphylococcal infection |
| 126171162 | 12617116 | 8 | Staphylococcal infection |
| 126171162 | 12617116 | 9 | Staphylococcal infection |
| 126171162 | 12617116 | 10 | Enterococcus test positive |
| 126171162 | 12617116 | 11 | Bacterial infection |
| 126171162 | 12617116 | 13 | Enterobacter infection |
| 126171162 | 12617116 | 16 | Staphylococcal infection |
| 126171162 | 12617116 | 17 | Enterobacter infection |
| 126171162 | 12617116 | 18 | Staphylococcal infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126171162 | 12617116 | HO |
| 126171162 | 12617116 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126171162 | 12617116 | Drug ineffective | |
| 126171162 | 12617116 | Drug resistance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |